ATE486093T1 - Antikörper, die spezifische für probnp(1-108) sind, und ihre verwendung zur diagnose von herzinfarkt - Google Patents

Antikörper, die spezifische für probnp(1-108) sind, und ihre verwendung zur diagnose von herzinfarkt

Info

Publication number
ATE486093T1
ATE486093T1 AT03756532T AT03756532T ATE486093T1 AT E486093 T1 ATE486093 T1 AT E486093T1 AT 03756532 T AT03756532 T AT 03756532T AT 03756532 T AT03756532 T AT 03756532T AT E486093 T1 ATE486093 T1 AT E486093T1
Authority
AT
Austria
Prior art keywords
pro
probnp
iii
ser
arg
Prior art date
Application number
AT03756532T
Other languages
English (en)
Inventor
Bernard Pau
Isabelle Giuliani
Francois Rieunier
Original Assignee
Bio Rad Pasteur
Centre Nat Rech Scient
Univ Montpellier I
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Rad Pasteur, Centre Nat Rech Scient, Univ Montpellier I filed Critical Bio Rad Pasteur
Application granted granted Critical
Publication of ATE486093T1 publication Critical patent/ATE486093T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/58—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Cardionatrin; Cardiodilatin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT03756532T 2002-08-07 2003-08-07 Antikörper, die spezifische für probnp(1-108) sind, und ihre verwendung zur diagnose von herzinfarkt ATE486093T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0210063A FR2843396B1 (fr) 2002-08-07 2002-08-07 Anticorps specifiques pour le diagnostic de l'insuffisance cardiaque
PCT/FR2003/002483 WO2004014952A2 (fr) 2002-08-07 2003-08-07 Anticorps specifiques du probnp (1-108) pour le diagnostic de l'insuffisance cardiaque

Publications (1)

Publication Number Publication Date
ATE486093T1 true ATE486093T1 (de) 2010-11-15

Family

ID=30470996

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03756532T ATE486093T1 (de) 2002-08-07 2003-08-07 Antikörper, die spezifische für probnp(1-108) sind, und ihre verwendung zur diagnose von herzinfarkt

Country Status (12)

Country Link
US (1) US7553937B2 (de)
EP (1) EP1527101B1 (de)
JP (1) JP4576232B2 (de)
CN (1) CN100467489C (de)
AT (1) ATE486093T1 (de)
AU (1) AU2003282194B2 (de)
CA (1) CA2494140C (de)
DE (1) DE60334696D1 (de)
ES (1) ES2354608T3 (de)
FR (1) FR2843396B1 (de)
RU (1) RU2315773C2 (de)
WO (1) WO2004014952A2 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7524635B2 (en) * 2003-04-17 2009-04-28 Biosite Incorporated Methods and compositions for measuring natriuretic peptides and uses thereof
AT500800B1 (de) * 2004-09-08 2008-07-15 Biomedica Medizinprodukte Gmbh Verfahren zur bestimmung von probnp
US7300494B2 (en) * 2005-02-24 2007-11-27 Hamilton Sundstrand Corporation On-board inert gas generation system with compressor surge protection
DE102007010834A1 (de) * 2007-03-03 2008-09-04 Brahms Aktiengesellschaft Diagnose und Risikostratifizierung von Herzinsuffizienz für NYHA I Patienten
AT504942B1 (de) 2007-03-07 2009-08-15 Biomedica Medizinprodukte Gmbh Verfahren zur bestimmung von probnp
WO2010012509A1 (en) * 2008-08-01 2010-02-04 Bio-Rad Pasteur Method for the in vitro diagnosis of stroke
FR2919611B1 (fr) 2007-08-03 2009-10-23 Bio Rad Pasteur Sa Nouvel epitope du bnp (1-32) et anticorps diriges contre cet epitope
DK2222697T3 (da) * 2007-11-01 2013-03-11 Perseid Therapeutics Llc Immunsuppressive polypeptider og nukleinsyrer
US9366680B2 (en) * 2008-08-28 2016-06-14 Shimadzu Corporation Method for evaluating myocardial ischemic state using blood sample
CN102334031B (zh) * 2008-12-08 2014-10-08 美艾利尔圣地亚哥有限公司 组合的尿钠肽检测
CA2751090A1 (en) * 2009-01-30 2010-08-05 Bio-Rad Innovations Method for the in vitro diagnosis of stroke
JP5362487B2 (ja) * 2009-08-27 2013-12-11 塩野義製薬株式会社 ｐｒｏＢＮＰ−１０８の新規用途
EP2478367B2 (de) 2009-09-14 2018-04-04 Koninklijke Philips N.V. Hochsensitiver Immunoassay mit grossen Partikelmarkern
US20120021431A1 (en) * 2010-02-25 2012-01-26 Toshio Nishikimi Diagnostic methods using bnp
EP2601531A1 (de) 2010-08-04 2013-06-12 IDEXX Laboratories, Inc. Nachweis von zersetzungsprodukten von hundespezifischem nt-probnp
US8407182B1 (en) 2011-01-21 2013-03-26 Symantec Corporation Systems and methods for facilitating long-distance live migrations of virtual machines
US8527990B1 (en) 2011-04-29 2013-09-03 Symantec Corporation Systems and methods for migrating virtual machines
WO2012166918A1 (en) 2011-05-31 2012-12-06 Idexx Laboratories, Inc. DETECTION OF DEGRADATION PRODUCTS OF FELINE NT-proBNP
CN102887943B (zh) * 2012-08-30 2016-08-03 重庆业为基生物科技有限公司 氨基末端脑钠肽的b细胞表位肽段及其应用
CN103012595B (zh) * 2012-12-17 2014-05-21 同昕生物技术（北京）有限公司 稳定的NT-proBNP校准品及应用
RU2569458C1 (ru) * 2014-12-02 2015-11-27 Федеральное государственное бюджетное учреждение "Российский кардиологический научно-производственный комплекс" Министерства здравоохранения России (ФГБУ "РКНПК" МЗ РФ) Способ диагностики хронической сердечной недостаточности путем использования циркулирующих уровней микрорнк
RU2569459C1 (ru) * 2014-12-02 2015-11-27 Федеральное государственное бюджетное учреждение "Российский кардиологический научно-производственный комплекс" Министерства здравоохранения России (ФГБУ "РКНПК" МЗ РФ) Способ дифференциальной диагностики этиологии хронической сердечной недостаточности
US10368774B2 (en) 2015-07-30 2019-08-06 Medtronic, Inc. Absolute intrathoracic impedance based scheme to stratify patients for risk of a heart failure event
CN105349545A (zh) * 2015-12-14 2016-02-24 中国人民解放军军事医学科学院基础医学研究所 一种NT-proBNP核酸适配体及其应用
US11931207B2 (en) 2018-12-11 2024-03-19 Eko.Ai Pte. Ltd. Artificial intelligence (AI) recognition of echocardiogram images to enhance a mobile ultrasound device
US12001939B2 (en) 2018-12-11 2024-06-04 Eko.Ai Pte. Ltd. Artificial intelligence (AI)-based guidance for an ultrasound device to improve capture of echo image views
US11446009B2 (en) 2018-12-11 2022-09-20 Eko.Ai Pte. Ltd. Clinical workflow to diagnose heart disease based on cardiac biomarker measurements and AI recognition of 2D and doppler modality echocardiogram images
CN109678958B (zh) * 2019-01-31 2022-03-18 重庆探生科技有限公司 一种人NT-proBNP特异性重组羊单克隆抗体及其制备方法和应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9211686D0 (en) * 1992-06-03 1992-07-15 Medisinsk Innovation A S Chemical compounds
DK2292662T3 (da) * 1996-03-04 2014-05-05 Scios Inc ASSAY OG REAGENSER TIL KVANTIFICERING AF hBNP
DK1016867T3 (da) * 1997-09-11 2006-05-22 Shionogi & Co Fremgangsmåde til immunassay af BNP
US6117644A (en) * 1998-06-04 2000-09-12 Ottawa Heart Institute Research Corporation Predicting and detecting cardiac allograft rejection
GB9827348D0 (en) * 1998-12-12 1999-02-03 Univ Leicester Natriuretic peptide
WO2000045176A2 (de) * 1999-01-29 2000-08-03 Roche Diagnostics Gmbh VERFAHREN ZUM NACHWEIS VON N-TERMINALEM proBNP
AUPS169202A0 (en) * 2002-04-11 2002-05-16 Goetze, Jens Peter Neuropeptide assay
WO2004094460A2 (en) * 2003-04-17 2004-11-04 Ciphergen Biosystems, Inc. Polypeptides related to natriuretic peptides and methods of their identification and use
PL2256132T3 (pl) * 2003-05-12 2016-08-31 Hoffmann La Roche Sposób wykrywania proBNP z zastosowaniem przeciwciała monoklonalnego
DE10355731A1 (de) * 2003-11-28 2005-06-30 Roche Diagnostics Gmbh Analytischer Sandwichtest zur Bestimmung von NT-proBNP

Also Published As

Publication number Publication date
AU2003282194A1 (en) 2004-02-25
US7553937B2 (en) 2009-06-30
CA2494140C (fr) 2011-11-01
WO2004014952A2 (fr) 2004-02-19
FR2843396A1 (fr) 2004-02-13
US20070299016A1 (en) 2007-12-27
RU2315773C2 (ru) 2008-01-27
DE60334696D1 (de) 2010-12-09
WO2004014952A3 (fr) 2004-04-08
RU2005106230A (ru) 2005-10-10
FR2843396B1 (fr) 2005-04-15
EP1527101A2 (de) 2005-05-04
CN100467489C (zh) 2009-03-11
AU2003282194B2 (en) 2008-10-30
EP1527101B1 (de) 2010-10-27
CN1678635A (zh) 2005-10-05
JP2006514609A (ja) 2006-05-11
JP4576232B2 (ja) 2010-11-04
ES2354608T3 (es) 2011-03-16
CA2494140A1 (fr) 2004-02-19

Similar Documents

Publication Publication Date Title
ATE486093T1 (de) Antikörper, die spezifische für probnp(1-108) sind, und ihre verwendung zur diagnose von herzinfarkt
EP1625163B8 (de) Verfahren zum nachweis von probnp mit einem monoklonalen antikörper, der die amino saüre 38-43 bindet
ATE440868T1 (de) Monoklonaler antikírper gegen ein prion protein und dessen verwendung zum nachweis von prionen
ATE402267T1 (de) Verfahren zur herstellung von monoklonalen antikörpern
HK1089232A1 (en) Use of a midregional proadrenomedullin partial peptide in biological fluids in the production of immological diagnostic agents
NO20013698L (no) Fremgangsmåte for identifisering av N-terminalt proBNP
FI3718564T3 (fi) Uusia anti-IL 13 -vasta-aineita ja niiden käyttöjä
RU2008130898A (ru) Антитело против периостина и содержащая его фармацевтическая композиция для профилактики или лечения заболевания, в развитии которого участвует периостин
DE60014124D1 (de) Antikörper, die spezifisch für fullerene sind
RU2010107618A (ru) Новый эпитоп bnp (1-32) и антитела, направленные против указанного эпитопа
RU2012129732A (ru) Агрегация, зависящая от последовательностей
CN108700576A (zh) 制备抗体对的方法、试剂盒及试剂盒的应用和制备抗体对的系统
ATE335763T1 (de) Sandwich-immunoassay zur bestimmung von proanp- teilpeptiden
CN101970456B (zh) 标签肽及其应用
EP0401370B1 (de) Enzymimmuntest für menschliches typiv-collagen gemäss dem sandwichverfahren
KR860006989A (ko) 인체의 심방의, 나트륨 이뇨성 펩티드에 대한 모노클론 항체
ATE390443T1 (de) Monoklonale antikörper zur selektiven immunologischen bestimmung von hochmolekularen, intakten lamininformen in körperflüssigkeiten
CN110352351A (zh) 使用抗人bnp片段(4-32)抗体的免疫测定方法
CN111100202A (zh) 针对蛋白标签Streptactin的人源单克隆抗体
백세환 et al. Simultaneous Dual-Enzyme Immunoassays in a Solid Phase
ATE382639T1 (de) Anti-humane thymidylat-synthase monoklonale antikörper und hybridomazellen zu deren herstellung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1527101

Country of ref document: EP

EEFA Change of the company name